The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …

Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only …

The precocity and efficacy of the vaccines developed so far against COVID-19 has been the
most significant and saving advance against the pandemic. The development of vaccines …

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there have
been multiple peaks of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus …

Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has resulted in a catastrophic pandemic and …

Convalescent plasma (CP) from patients recovered from COVID-19 is one of the most
studied anti-viral therapies against SARS-COV-2 infection. The aim of this study is to …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic is ongoing and many drugs
have been studied in clinical trials. From a pathophysiological perspective, anti‐viral drugs …

The use of the serum or plasma of patients or animals who have recovered from an
infectious disease, or had been immunized with a relevant antigen, to treat or prevent the …

Coronavirus 2019 disease (COVID-19) represents one of the largest pandemics the world
has faced, and it is producing a global health crisis. To date, the availability of drugs to treat …

Introducción Durante la pandemia de COVID-19 surgieron diversas estrategias para el
manejo de la enfermedad, incluidos los tratamientos farmacológicos y no farmacológicos …